{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "SARS-CoV-2 main protease", "drug repurposing", "in-silico drug discovery", "molecular dynamics"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32684114", "DateCompleted": {"Year": "2021", "Month": "09", "Day": "08"}, "DateRevised": {"Year": "2021", "Month": "09", "Day": "08"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "07", "Day": "20"}], "Language": ["eng"], "ELocationID": ["10.1080/07391102.2020.1791958"], "Journal": {"ISSN": "1538-0254", "JournalIssue": {"Volume": "39", "Issue": "15", "PubDate": {"Year": "2021", "Month": "Sep"}}, "Title": "Journal of biomolecular structure & dynamics", "ISOAbbreviation": "J Biomol Struct Dyn"}, "ArticleTitle": "<i>In-silico</i> drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors.", "Pagination": {"StartPage": "5756", "EndPage": "5767", "MedlinePgn": "5756-5767"}, "Abstract": {"AbstractText": ["Herein, the DrugBank database which contains 10,036 approved and investigational drugs was explored deeply for potential drugs that target SARS-CoV-2 main protease (M<sup>pro</sup>). Filtration process of the database was conducted using three levels of accuracy for molecular docking calculations. The top 35 drugs with docking scores >\u2009-11.0\u2009kcal/mol were then subjected to 10\u2009ns molecular dynamics (MD) simulations followed by molecular mechanics-generalized Born surface area (MM-GBSA) binding energy calculations. The results showed that DB02388 and Cobicistat (DB09065) exhibited potential binding affinities towards M<sup>pro</sup> over 100\u2009ns MD simulations, with binding energy values of -49.67 and -46.60\u2009kcal/mol, respectively. Binding energy and structural analyses demonstrated the higher stability of DB02388 over Cobicistat. The potency of DB02388 and Cobicistat is attributed to their abilities to form several hydrogen bonds with the essential amino acids inside the active site of M<sup>pro</sup>. Compared to DB02388 and Cobicistat, Darunavir showed a much lower binding affinity of -34.83\u2009kcal/mol. The present study highlights the potentiality of DB02388 and Cobicistat as anti-COVID-19 drugs for clinical trials. Communicated by Ramaswamy H. Sarma."]}, "AuthorList": [{"Identifier": ["0000-0003-4819-2040"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia, Egypt."}], "LastName": "Ibrahim", "ForeName": "Mahmoud A A", "Initials": "MAA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia, Egypt."}], "LastName": "Abdelrahman", "ForeName": "Alaa H M", "Initials": "AHM"}, {"Identifier": ["0000-0002-0343-4969"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry of Medicinal Plants Department, National Research Centre, Giza, Egypt."}], "LastName": "Hegazy", "ForeName": "Mohamed-Elamir F", "Initials": "MF"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Biomol Struct Dyn", "NlmUniqueID": "8404176", "ISSNLinking": "0739-1102"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Drug Repositioning"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": [], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}], "CoiStatement": "No potential conflict of interest was reported by the author(s)."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Bayly, C. I., Cieplak, P., Cornell, W., & Kollman, P. A. (1993). A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: The RESP model. The Journal of Physical Chemistry, 97(40), 10269\u201310280. 10.1021/j100142a004", "ArticleIdList": ["10.1021/j100142a004"]}, {"Citation": "Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A., & Haak, J. R. (1984). Molecular-dynamics with coupling to an external bath. The Journal of Chemical Physics, 81(8), 3684\u20133690. 10.1063/1.448118", "ArticleIdList": ["10.1063/1.448118"]}, {"Citation": "Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., Li, X., Xia, J., Chen, N., Xiang, J., Yu, T., Bai, T., Xie, X., Zhang, L., Li, C., \u2026 Wang, C. (2020). A trial of Lopinavir-Ritonavir in adults hospitalized with severe Covid-19. The New England Journal of Medicine, 382(19), 1787\u20131799. 10.1056/NEJMoa2001282", "ArticleIdList": ["10.1056/NEJMoa2001282", "PMC7121492", "32187464"]}, {"Citation": "Case, D. A., Betz, R. M., Cerutti, D. S., Cheatham, T. E., Darden, T. A., Duke, R. E., Giese, T. J., Gohlke, H., Goetz, A. W., Homeyer, N., Izadi, S., Janowski, P., Kaus, J., Kovalenko, A., Lee, T. S., LeGrand, S., Li, P., Lin, C., Luchko, T., ... Kollman, P. A. (2016). AMBER 2016. University of California."}, {"Citation": "Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: AnN\u22c5log(N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089\u201310092. 10.1063/1.464397", "ArticleIdList": ["10.1063/1.464397"]}, {"Citation": "Deeks, E. D. (2014). Cobicistat: A review of its use as a pharmacokinetic enhancer of Atazanavir and Darunavir in patients with HIV-1 infection. Drugs, 74(2), 195\u2013206. 10.1007/s40265-013-0160-x", "ArticleIdList": ["10.1007/s40265-013-0160-x", "24343782"]}, {"Citation": "Elmezayen, A. D., Al-Obaidi, A., \u015eahin, A. T., & Yelek\u00e7i, K. (2020). Drug repurposing for coronavirus (COVID-19): In silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. Journal of Biomolecular Structure and Dynamics, 1\u201313. 10.1080/07391102.2020.1758791", "ArticleIdList": ["10.1080/07391102.2020.1758791", "PMC7189413", "32306862"]}, {"Citation": "Ferreira, L. G., Dos Santos, R. N., Oliva, G., & Andricopulo, A. D. (2015). Molecular docking and structure-based drug design strategies. Molecules (Basel, Switzerland), 20(7), 13384\u201313421. 10.3390/molecules200713384", "ArticleIdList": ["10.3390/molecules200713384", "PMC6332083", "26205061"]}, {"Citation": "Forli, S., Huey, R., Pique, M. E., Sanner, M. F., Goodsell, D. S., & Olson, A. J. (2016). Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nature Protocols, 11(5), 905\u2013919. 10.1038/nprot.2016.051", "ArticleIdList": ["10.1038/nprot.2016.051", "PMC4868550", "27077332"]}, {"Citation": "Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., Scalmani, G., Barone, V., Mennucci, B., Petersson, G. A., Nakatsuji, H., Caricato, M., Li, X., Hratchian, H. P., Izmaylov, A. F., Bloino, J., Zheng, G., Sonnenberg, J. L., Hada, M., Ehara, M., ... Fox, D. J. (2009). Gaussian 09 (Version Revision E01). Gaussian Inc."}, {"Citation": "Gao, J., Tian, Z., & Yang, X. (2020). Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Bioscience Trends, 14(1), 72\u201373. 10.5582/bst.2020.01047", "ArticleIdList": ["10.5582/bst.2020.01047", "32074550"]}, {"Citation": "Gasteiger, J., & Marsili, M. (1980). Iterative partial equalization of orbital electronegativity - a rapid access to atomic charges. Tetrahedron, 36(22), 3219\u20133228. 10.1016/0040-4020(80)80168-2", "ArticleIdList": ["10.1016/0040-4020(80)80168-2"]}, {"Citation": "Gordon, J. C., Myers, J. B., Folta, T., Shoja, V., Heath, L. S., & Onufriev, A. (2005). H++: A server for estimating pKas and adding missing hydrogens to macromolecules. Nucleic Acids Research, 33(Web Server issue), W368\u2013W371. 10.1093/nar/gki464", "ArticleIdList": ["10.1093/nar/gki464", "PMC1160225", "15980491"]}, {"Citation": "Guedes, I. A., de Magalh\u00e3es, C. S., & Dardenne, L. E. (2014). Receptor-ligand molecular docking. Biophysical Reviews, 6(1), 75\u201387. 10.1007/s12551-013-0130-2", "ArticleIdList": ["10.1007/s12551-013-0130-2", "PMC5425711", "28509958"]}, {"Citation": "Harrison, C. (2020). Coronavirus puts drug repurposing on the fast track. Nature Biotechnology, 38(4), 379\u2013381. 10.1038/d41587-020-00003-1", "ArticleIdList": ["10.1038/d41587-020-00003-1", "32205870"]}, {"Citation": "Hawkins, P. C. D., Skillman, A. G., Warren, G. L., Ellingson, B. A., & Stahl, M. T. (2010). Conformer generation with OMEGA: Algorithm and validation using high quality structures from the protein databank and Cambridge structural database. Journal of Chemical Information and Modeling, 50(4), 572\u2013584. 10.1021/ci100031x", "ArticleIdList": ["10.1021/ci100031x", "PMC2859685", "20235588"]}, {"Citation": "Hilgenfeld, R. (2014). From SARS to MERS: Crystallographic studies on coronaviral proteases enable antiviral drug design. The FEBS Journal, 281(18), 4085\u20134096. 10.1111/febs.12936", "ArticleIdList": ["10.1111/febs.12936", "PMC7163996", "25039866"]}, {"Citation": "Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33\u201338. 10.1016/0263-7855(96)00018-5", "ArticleIdList": ["10.1016/0263-7855(96)00018-5", "8744570"]}, {"Citation": "Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., \u2026 Yang, H. (2020). Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582(7811), 289\u2013293. 10.1038/s41586-020-2223-y", "ArticleIdList": ["10.1038/s41586-020-2223-y", "32272481"]}, {"Citation": "Karaman, B., & Sippl, W. (2019). Computational drug repurposing: Current trends. Current Medicinal Chemistry, 26(28), 5389\u20135409. 10.2174/0929867325666180530100332", "ArticleIdList": ["10.2174/0929867325666180530100332", "29848268"]}, {"Citation": "Khan, R. J., Jha, R. K., Amera, G. M., Jain, M., Singh, E., Pathak, A., Singh, R. P., Muthukumaran, J., & Singh, A. K. (2020). Targeting SARS-CoV-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2\u2032-O-ribose methyltransferase. Journal of Biomolecular Structure and Dynamics, 1\u201314. 10.1080/07391102.2020.1753577", "ArticleIdList": ["10.1080/07391102.2020.1753577", "PMC7189412", "32266873"]}, {"Citation": "Khan, S. A., Zia, K., Ashraf, S., Uddin, R., & Ul-Haq, Z. (2020). Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. Journal of Biomolecular Structure and Dynamics, 1\u201310. 10.1080/07391102.2020.1751298", "ArticleIdList": ["10.1080/07391102.2020.1751298", "32238094"]}, {"Citation": "Lai, C.-C., Shih, T.-P., Ko, W.-C., Tang, H.-J., & Hsueh, P.-R. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International Journal of Antimicrobial Agents, 55(3), 105924\u2013105932. 10.1016/j.ijantimicag.2020.105924", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105924", "PMC7127800", "32081636"]}, {"Citation": "Laskowski, R. A., & Swindells, M. B. (2011). LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. Journal of Chemical Information and Modeling, 51(10), 2778\u20132786. 10.1021/ci200227u", "ArticleIdList": ["10.1021/ci200227u", "21919503"]}, {"Citation": "Luo, H., Tang, Q.-L., Shang, Y.-X., Liang, S.-B., Yang, M., Robinson, N., & Liu, J.-P. (2020). Can Chinese medicine be used for prevention of Corona Virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs. Chinese Journal of Integrative Medicine, 26(4), 243\u2013250. 10.1007/s11655-020-3192-6", "ArticleIdList": ["10.1007/s11655-020-3192-6", "PMC7088641", "32065348"]}, {"Citation": "Maier, J. A., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K. E., & Simmerling, C. (2015). ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. Journal of Chemical Theory and Computation, 11(8), 3696\u20133713. 10.1021/acs.jctc.5b00255", "ArticleIdList": ["10.1021/acs.jctc.5b00255", "PMC4821407", "26574453"]}, {"Citation": "Massova, I., & Kollman, P. A. (2000). Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding. Perspectives in Drug Discovery and Design, 18(1), 113\u2013135. 10.1023/A:1008763014207", "ArticleIdList": ["10.1023/A:1008763014207"]}, {"Citation": "Meng, X.-Y., Zhang, H.-X., Mezei, M., & Cui, M. (2011). Molecular docking: A powerful approach for structure-based drug discovery. Current Computer-Aided Drug Design, 7(2), 146\u2013157. 10.2174/157340911795677602", "ArticleIdList": ["10.2174/157340911795677602", "PMC3151162", "21534921"]}, {"Citation": "Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785\u20132791. 10.1002/jcc.21256", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}, {"Citation": "OMEGA . (2013). OMEGA (Version 2.5.1.4). OpenEye Scientific Software."}, {"Citation": "Pagadala, N. S., Syed, K., & Tuszynski, J. (2017). Software for molecular docking: A review. Biophysical Reviews, 9(2), 91\u2013102. 10.1007/s12551-016-0247-1", "ArticleIdList": ["10.1007/s12551-016-0247-1", "PMC5425816", "28510083"]}, {"Citation": "Pantsar, T., & Poso, A. (2018). Binding affinity via docking: Fact and fiction. Molecules, 23(8), 1899\u20131909. 10.3390/molecules23081899", "ArticleIdList": ["10.3390/molecules23081899", "PMC6222344", "30061498"]}, {"Citation": "Pushpakom, S., Iorio, F., Eyers, P. A., Escott, K. J., Hopper, S., Wells, A., Doig, A., Guilliams, T., Latimer, J., McNamee, C., Norris, A., Sanseau, P., Cavalla, D., & Pirmohamed, M. (2019). Drug repurposing: Progress, challenges and recommendations. Nature Reviews. Drug Discovery, 18(1), 41\u201358. 10.1038/nrd.2018.168", "ArticleIdList": ["10.1038/nrd.2018.168", "30310233"]}, {"Citation": "Scapin, G., Patel, S. B., Lisnock, J., Becker, J. W., & LoGrasso, P. V. (2003). The structure of JNK3 in complex with small molecule inhibitors: Structural basis for potency and selectivity. Chemistry & Biology, 10(8), 705\u2013712. 10.1016/S1074-5521(03)00159-5", "ArticleIdList": ["10.1016/S1074-5521(03)00159-5", "12954329"]}, {"Citation": "SZYBKI . (2016). SZYBKI (Version 1.9.0.3). OpenEye Scientific Software."}, {"Citation": "Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry, 25(9), 1157\u20131174. 10.1002/jcc.20035", "ArticleIdList": ["10.1002/jcc.20035", "15116359"]}, {"Citation": "Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., Assempour, N., Iynkkaran, I., Liu, Y., Maciejewski, A., Gale, N., Wilson, A., Chin, L., Cummings, R., Le, D., \u2026 Wilson, M. (2018). DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Research, 46(D1), D1074\u2013D1082. 10.1093/nar/gkx1037", "ArticleIdList": ["10.1093/nar/gkx1037", "PMC5753335", "29126136"]}, {"Citation": "Wishart, D. S., Knox, C., Guo, A. C., Shrivastava, S., Hassanali, M., Stothard, P., Chang, Z., & Woolsey, J. (2006). DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Research, 34(Database issue), D668\u2013D672. 10.1093/nar/gkj067", "ArticleIdList": ["10.1093/nar/gkj067", "PMC1347430", "16381955"]}, {"Citation": "Xue, X., Yu, H., Yang, H., Xue, F., Wu, Z., Shen, W., Li, J., Zhou, Z., Ding, Y., Zhao, Q., Zhang, X. C., Liao, M., Bartlam, M., & Rao, Z. (2008). Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design. Journal of Virology, 82(5), 2515\u20132527. 10.1128/JVI.02114-07", "ArticleIdList": ["10.1128/JVI.02114-07", "PMC2258912", "18094151"]}, {"Citation": "Yella, J., Yaddanapudi, S., Wang, Y., & Jegga, A. (2018). Changing trends in computational drug repositioning. Pharmaceuticals (Pharmaceuticals), 11(2), 57\u201378. 10.3390/ph11020057", "ArticleIdList": ["10.3390/ph11020057", "PMC6027196", "29874824"]}, {"Citation": "Zhao, Q., Weber, E., & Yang, H. (2013). Recent developments on coronavirus main protease/3C like protease inhibitors. Recent Patents on anti-Infective Drug Discovery, 8(2), 150\u2013156. 10.2174/1574891x113089990017", "ArticleIdList": ["10.2174/1574891x113089990017", "23879823"]}]}], "History": [{"Year": "2020", "Month": "7", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "21"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32684114", "PMC7441803", "10.1080/07391102.2020.1791958"]}}]}